南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

综合性三维基因组与表观基因组分析揭示,TP53RK和SYBU是肝细胞癌中维持干细胞特性及增强抗肿瘤免疫功能的关键调控因子。

Integrative 3D genome and epigenomic analysis identifies TP53RK and SYBU as critical regulators of stemness and anti-tumor immunity in HCC

Yanmei Yang, Peixian Li, Liangbo Zhao, Lingwei Zhang, Hong Chen, Hao Xing, Pingping Zhu, Jing An, Luyun He, Shuiling Jin, Nian Liu, Shuaixi Yang, Xiao Sun, Benyu Liu

Journal:Cell Reports

IF:7.7

DOI:10.1016/j.celrep.2026.117797

PMID:42570238

Published:2026-08-08

research field:免疫学微生物学病理学

Abstract

Three-dimensional (3D) genome organization plays a fundamental role in governing gene regulation and tumor cell properties. However, how higher-order chromatin architecture regulates stemness in hepatocellular carcinoma (HCC) remains unclear. Here, we delineated the 3D chromatin landscapes of well- and poorly differentiated HCC cells and uncovered stemness-associated rewiring of A/B compartmentalization, topologically associating domain (TAD) boundaries, and enhancer-promoter loops. These structural alterations lead to the differential expression of TP53RK and SYBU , which exert opposing effects on HCC stemness and progression. TP53RK promotes tumor stemness by enhancing mitophagy, whereas SYBU suppresses stemness by inhibiting MAPK signaling. Notably, TP53RK expression correlates positively with PD-1, and the combined inhibition of TP53RK and PD-1 markedly enhances anti-tumor immunity. Our findings identify the 3D genome architecture as a key determinant of tumor stemness and highlight TP53RK as a promising therapeutic target in HCC.

本文使用的Yeasen产品

购物车
客服
转染试用